EPO Patents = 1

Forward Citations = 12

Loading Chart...

5 inventors (with patents filed for the assignee):

Carolyn Durham (7 out of 7 patents)

Dan Copeland (5 out of 5 patents)

Thomas E Richardson (2 out of 21 patents)

4. Edward J Delaney (2 out of 8 patents)

5. Daniel W Copeland (2 out of 2 patents)

7 patents: Sort by Forward Citations

1. 12427180 - Treatment of respiratory tract diseases and infections with ascorbic acid compositions (2025-09-30),

2. 12419932 - Aqueous solution comprising a glutathione salt (2025-09-23),

3. 12350307 - Stable ascorbic acid compositions and methods of using same (2025-07-08),

4. 12097238 - Aqueous solution comprising a glutathione salt (2024-09-24),

5. 11890315 - Stable ascorbic acid compositions and methods of using same (2024-02-06),

6. 11602555 - Treatment of respiratory tract diseases and infections with ascorbic acid compositions (2023-03-14),

7. 11497786 - Stable ascorbic acid compositions and methods of using the same (2022-11-15),

Company Overview

Renovion, Inc. is a biotechnology company focused on developing novel therapies for respiratory diseases. Founded in 2015, the company is dedicated to improving the lives of patients with asthma, chronic obstructive pulmonary disease (COPD), and other lung conditions. Renovion is committed to utilizing innovative technologies to create effective and safe treatments for respiratory disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#15 in Chapel Hill, NC

#857 in North Carolina

#39,907 in US

Chapel Hill, NC, United States of America

Renovion, Inc.

Forward Citations = 12

5 inventors:

Carolyn Durham (7 out of 7 patents)

Dan Copeland (5 out of 5 patents)

Thomas E Richardson (2 out of 21 patents)

4. Edward J Delaney (2 out of 8 patents)

5. Daniel W Copeland (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Renovion, Inc.. Retrieved from https://idiyas.com/company/renovion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]